1. To learn the new nomenclature for NAFLD and NASH.
2. To understand the optimal care pathway for patients with NAFLD/MASLD.
3. To be aware of current management options and emerging therapies.
11/21/2023 - 4:30pm to 5:30pm CST
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Dr. Mary Rinella